Mibiome Therapeutics Llp - business services in Jogeshwart West Mumbai, Maharashtra, India. FY 2026 financials and compliance.
LLPIN AAP-3186 Incorporated 16 May 2019 ROC Mumbai HQ Jogeshwart West Mumbai, Maharashtra, India
Active Limited Liability Partnership business services
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
Locked
In full report
Net profit · Latest
Locked
In full report
Contribution obligation
₹1 Lakh
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
None
Secured borrowings
Company age
7 yrs
Est. 2019
Last financials
Mar 2025
Balance sheet date

About Mibiome Therapeutics Llp

Data last updated: 06 February 2026

Mibiome Therapeutics Llp is a limited liability partnership company based in Jogeshwart West Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It specialises in service-based operations, a part of the broader business services sector. Incorporated on 16 May 2019, the LLP has been in operation for over 7 years.

Registered with ROC Mumbai under LLPIN AAP-3186.

Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners Gautam Das and Ravi Ashwin Shroff.

Accounts filed on 31 March 2025. Office: Flexcel Park C Wing 2Nd Floor S. V. Road Near 24 Karat Multiplex, Jogeshwart West Mumbai, Maharashtra, India – 400102.

The LLP is associated with 2 brands - Anshul Specialty Molecules, Mibiome Therapeutics.

For more details, the LLP can be reached via its website mibiome.com.

Company Details of Mibiome Therapeutics Llp
LLPIN AAP-3186
Incorporation Date 16 May 2019
Total Obligation of Contribution ₹1 Lakh
ROC Mumbai
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    Flexcel Park C Wing 2Nd Floor S. V. Road Near 24 Karat Multiplex, Jogeshwart West Mumbai, Maharashtra, India – 400102
  • Industry
    Business Services, Other Services
Company report
Mibiome Therapeutics Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Mibiome Therapeutics Llp report

Financials, compliance, directors, charges, ownership and filings for Mibiome Therapeutics Llp in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Mibiome Therapeutics Llp

Mibiome Therapeutics Llp operates two associated brands: Anshul Specialty Molecules and miBiome Therapeutics. These brands represent Mibiome Therapeutics Llp's diversified market presence and brand portfolio.

Brand Description Website
Produces high-quality specialty chemicals for APIs, flavors, fragrances, and custom synthesis. anshulchemicals.com
Offers genomic sequencing, consulting, and analytics for research purposes. mibiome.com

Competitors & Alternatives of Mibiome Therapeutics Llp

Brands and companies operating in the same space as Mibiome Therapeutics Llp include Laurus Labs, Symbiotec, BGI and 7 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
BGI BGI BGI is engaged in genomics and precision medicine solutions. Shenzhen, China, China 1999
Genewiz Genewiz Genomic services are provided for the life sciences industry. South Plainfield, United States, United States 1999
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Macrogen Macrogen Next-generation sequencing and genomics services are provided globally. Seoul, South Korea, South Korea 1997
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
CosmosID CosmosID Next-generation sequencing technologies for microorganism detection are developed. Rockville, United States, United States 2008

Designated Partners of Mibiome Therapeutics Llp

Mibiome Therapeutics Llp is currently managed by 2 designated partners, with 2 former designated partners having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Gautam Das Designated Partner 14 Nov 2020 5 Years 9 Months Current
Ravi Ashwin Shroff Designated Partner 16 May 2019 7 Years 3 Months Current

Financials of Mibiome Therapeutics Llp FY 2025 filings available

Premium access

Ten-year financial statements for Mibiome Therapeutics Llp

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings Mibiome Therapeutics Llp

Mibiome Therapeutics Llp does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Mibiome Therapeutics Llp

View historical data on people associated with Mibiome Therapeutics Llp, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Mibiome Therapeutics Llp

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Mibiome Therapeutics Llp

Premium access

GST registrations and filing compliance for Mibiome Therapeutics Llp

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Mibiome Therapeutics Llp

Premium access

Credit ratings, litigation, and regulatory alerts for Mibiome Therapeutics Llp

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Mibiome Therapeutics Llp

Premium access

MSME payment history for Mibiome Therapeutics Llp

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Mibiome Therapeutics Llp

Premium access

Corporate group structure for Mibiome Therapeutics Llp

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Mibiome Therapeutics Llp

Premium access

MCA filings and documents for Mibiome Therapeutics Llp

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Mibiome Therapeutics Llp

Activity
31 Mar 2025
Mibiome Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Activity
31 Mar 2025
Mibiome Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
14 Nov 2020
Gautam Das was appointed as a Designated Partner on 14 Nov 2020 & has been associated with this company since 5 years 9 months.
Directors
16 May 2019
Ravi Ashwin Shroff was appointed as a Designated Partner on 16 May 2019 & has been associated with this company since 7 years 3 months.
Activity
16 May 2019
Mibiome Therapeutics Llp was registered on 16 May 2019 with Roc Mumbai & aged 7 years 3 months as per MCA records.

Frequently Asked Questions about Mibiome Therapeutics Llp

Mibiome Therapeutics Llp is an active limited liability partnership in the business services sector based in Jogeshwart West Mumbai, Maharashtra, India. It was incorporated on 16 May 2019 (7+ years old) and is registered under LLPIN AAP-3186.

The current designated partners of Mibiome Therapeutics Llp are:

The primary industry of Mibiome Therapeutics Llp is business services. The LLP specifically operates in other services. The LLP is currently active in this sector.

Yes, Mibiome Therapeutics Llp is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Mibiome Therapeutics Llp can be reached at the registered office: Flexcel Park C Wing 2Nd Floor S. V. Road Near 24 Karat Multiplex, Jogeshwart West Mumbai, Maharashtra, India – 400102, or through the website mibiome.com.

The total obligation of contribution is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available